European framework to decrease the burden of TB/HIV

P. de Colombani, N. Banatvala, R. Zaleskis, D. Maher, T. Aleksandrina, A. Ball, D. Erzen, D. Farge-Bancel, P. Godfrey-Faussett, A. Infuso, S. Matic, G. B. Migliori, M. Bijl, H. Rieder, T. Shoumilina, J. Veen, I. Yordi Aguirre, B. Eramova, B. Hauer, J. LeeseP. Van Maaren, E. Pontali, P. Ramon-Pardo, A. Reid, J. Scholten, A. Thorson

Research output: Contribution to journalArticlepeer-review


Tuberculosis (TB) in Europe is declining in countries in western and central Europe, but the burden is still high and increasing in eastern Europe. HIV/AIDS is increasing dramatically in eastern Europe. HIV-related tuberculosis (TB/HIV) morbidity and mortality are expected to accelerate significantly in the future. This framework aims to guide European countries in developing their national plan for reducing TB/HIV morbidity and mortality. It results from an extensive consultation process undertaken by the World Health Organization Regional Office for Europe and by those responsible for HIV/AIDS and TB programmes and their partners. It builds on strategies developed globally and in Europe for TB control and for HIV/AIDS prevention and care. This framework sets out the rationale for effective collaboration between HIV/AIDS and tuberculosis national programmes. It identifies five strategic components (political commitment, collaborative prevention, intensified case-finding, coordinated treatment and strengthened surveillance) and eight key operations (central coordination, policy development, surveillance, training, supply management, service delivery, health promotion and research).

Original languageEnglish
Pages (from-to)493-501
Number of pages9
JournalEuropean Respiratory Journal
Issue number3
Publication statusPublished - Sep 2004


  • AIDS
  • Delivery of healthcare
  • Europe
  • Health policy
  • HIV infections
  • Tuberculosis

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine


Dive into the research topics of 'European framework to decrease the burden of TB/HIV'. Together they form a unique fingerprint.

Cite this